Volume control in peritoneal dialysis patients: Role of new dialysis solutions

被引:10
|
作者
Lameire, N [1 ]
机构
[1] Univ Hosp, Div Renal, BE-9000 Ghent, Belgium
关键词
biocompatibility; glucose degradation products; left ventricular hypertrophy; peritoneal dialysis; ultrafiltration failure; volume control;
D O I
10.1159/000074923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper reviews the most recent clinical data on the volume status of long-term peritoneal dialysis (PD) patients. It appears that many PD patients are volume overloaded, associated with a high prevalence of hypertension and left ventricular hypertrophy. In the presence of the poor results in patients with peritoneal ultrafiltration, the introduction of the polyglucose solution, icodextrin, has ameliorated volume control in some of these patients. In a second part of the review, some of the structural and functional alterations in the peritoneal membrane and the role of glucose degradation products (GDP) in the commonly used dialysates as well as the resulting formation of advanced glycation end products are described. The introduction of low GDP-containing solutions at normal pH has at least in experimental models of PD attenuated the hemodynamic changes observed with the classical solutions. The solutions at normal pH containing either bicarbonate or a mixture of bicarbonate/lactate were clinically associated with less inflow pain. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:44 / 54
页数:11
相关论文
共 50 条
  • [21] Peritoneal dialysis solutions
    Wang, T
    Lindholm, B
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 : S89 - S95
  • [22] Peritoneal dialysis solutions
    Gokal, R
    DIALYSIS & TRANSPLANTATION, 1996, 25 (10) : 667 - &
  • [23] Peritoneal dialysis solutions
    Montenegro, J.
    NEFROLOGIA, 2008, 28 : 59 - 65
  • [24] Volume Control in Peritoneal Dialysis Patients Guided by Bioimpedance Spectroscopy Assessment
    Luo, Ya-Jun
    Lu, Xin-Hong
    Woods, Feidhlim
    Wang, Tao
    BLOOD PURIFICATION, 2011, 31 (04) : 296 - 302
  • [25] CHARACTERIZING THE RESIDUAL VOLUME IN PERITONEAL DIALYSIS PATIENTS
    Lindholm, Elin
    Oberg, Carl
    Bergling, Karin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I872 - I873
  • [26] Extracellular volume expansion in peritoneal dialysis patients
    Fan, Stanley
    Sayed, Rabya H.
    Davenport, Andrew
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2012, 35 (05): : 338 - 345
  • [27] Phosphorus control in peritoneal dialysis patients
    Yavuz, A.
    Ersoy, F. F.
    Passadakis, P. S.
    Tam, P.
    Evaggelos, D. M.
    Katopodis, K. P.
    Oezener, C.
    Akcicek, F.
    Camsari, T.
    Ates, K.
    Ataman, R.
    Vlachojannis, G. J.
    Dombros, N. A.
    Utas, C.
    Akpolat, T.
    Bozfakioglu, S.
    Wu, G.
    Karayaylali, I.
    Arinsoy, T.
    Stathakis, C. P.
    Yavuz, M.
    Tsakiris, D. J.
    Dimitriades, A. C.
    Yilmaz, M. E.
    Gueltekin, M.
    Sueleymanlar, G.
    Oreopoulos, D. G.
    KIDNEY INTERNATIONAL, 2008, 73 : S152 - S158
  • [28] Use of new peritoneal dialysis solutions in children
    Canepa, A.
    Verrina, E.
    Perfumo, F.
    KIDNEY INTERNATIONAL, 2008, 73 : S137 - S144
  • [29] Clinical advantages of new peritoneal dialysis solutions
    Krediet, RT
    van Westrhenen, R
    Zweers, MM
    Struijk, DG
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 : 16 - 18
  • [30] Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions
    Cernaro, Valeria
    Calderone, Michela
    Gembillo, Guido
    Calabrese, Vincenzo
    Casuscelli, Chiara
    Lo Re, Claudia
    Longhitano, Elisa
    Santoro, Domenico
    NUTRIENTS, 2023, 15 (14)